Well, I think Mr. Keon and Ms. Cox would probably take issue with most generic drugs being produced in India, since they produce generic drugs in Canada. It is true there are economies of scale which are to be had in developing nations, so if most product ingredients that are the foundation of pharmaceutical products are already made in India and China and labour costs are lower there, you will see a flow of generic manufacturing—you already have seen a flow of generic manufacturing—to those markets. There's that, combined with the increasing size of the market, which can't be denied either, the growing middle class in India, for example.
That said, as I said before, we're not competing...we can't compete on that basis with those countries. We're competing with the European Union, the U.S., Japan, and other developed nations, on the innovative side of things.